Progressive Radiology LLC

Progressive Radiology LLC, a for-profit limited liability company headquartered in Montclair, New Jersey, operates exclusively as a prime contractor delivering interventional radiology physician services to the Department of Veterans Affairs, competing under full-and-open designation with no set-asides across its federal footprint. The vendor provides specialized medical procedures—angiography, biopsy, embolization, and drainage—at VA medical facilities across the northeastern United States, primarily through delivery orders placed against single-award indefinite-delivery contracts held with Veterans Integrated Service Network 2 and Veterans Integrated Service Network 12.

Progressive Radiology exhibits extreme customer concentration. Of 20 total awards spanning multiple years with a combined potential value of $41.9 million, 19 awards valued at $37.8 million flow through VISN 2 alone, accounting for 100% of decision-relevant activity. A single award to VISN 12 carries $4 million potential value. The vendor has no subcontract footprint; all awards are prime work performed directly by the company. The two largest parent vehicles are single-award IDCs: IDC 36C24223D0057 (6 task orders, $9.5 million combined potential value, ultimate completion June 30, 2027) and the Professional and Allied Healthcare Staffing Services GSA Schedule (6 task orders, $9.9 million combined potential value). A third IDC, 36C24226D0033, carries 1 task order valued at $900 thousand.

Recent representative work includes a $1,119,960 firm fixed-price delivery order from VISN 2 awarded July 1, 2026, for interventional radiology physician services at East Orange, New Jersey, running through June 30, 2028 (Option Year 3 funding); a $899,700 delivery order awarded February 1, 2026, for services in Bronx, New York through January 31, 2027; and a $1,079,200 delivery order awarded July 1, 2025, at Montclair, New Jersey through June 30, 2026. Activity is minimal and flat—two awards per year in 2022 through 2025, rising to three in 2026 to date. Only two awards totaling $2 million in combined potential value reach ultimate completion inside the next twenty-four months, presenting limited recompete exposure. Combined dollars obligated across all awards stand at $17.2 million, or 41% of the $41.9 million combined potential value.